Early diagnosis of acute coronary syndrome

The diagnostic evaluation of acute chest pain has been augmented in recent years by advances in the sensitivity and precision of cardiac troponin assays, new biomarkers, improvements in imaging modalities, and release of new clinical decision algorithms. This progress has enabled physicians to diagnose or rule-out acute myocardial infarction earlier after the initial patient presentation, usually in emergency department settings, which may facilitate prompt initiation of evidence-based treatments, investigation of alternative diagnoses for chest pain, or discharge, and permit better utilization of healthcare resources. A non-trivial proportion of patients fall in an indeterminate category according to rule-out algorithms, and minimal evidence-based guidance exists for the optimal evaluation, monitoring, and treatment of these patients. The Cardiovascular Round Table of the ESC proposes approaches for the optimal application of early strategies in clinical practice to improve patient care following the review of recent advances in the early diagnosis of acute coronary syndrome. The following specific 'indeterminate' patient categories were considered: (i) patients with symptoms and high-sensitivity cardiac troponin <99th percentile; (ii) patients with symptoms and high-sensitivity troponin <99th percentile but above the limit of detection; (iii) patients with symptoms and high-sensitivity troponin >99th percentile but without dynamic change; and (iv) patients with symptoms and high-sensitivity troponin >99th percentile and dynamic change but without coronary plaque rupture/erosion/dissection. Definitive evidence is currently lacking to manage these patients whose early diagnosis is 'indeterminate' and these areas of uncertainty should be assigned a high priority for research.

[1]  G. Burke,et al.  The HEART Pathway Randomized Trial: Identifying Emergency Department Patients With Acute Chest Pain for Early Discharge , 2014, Circulation. Cardiovascular quality and outcomes.

[2]  Eric Boerwinkle,et al.  Cardiac Troponin T Measured by a Highly Sensitive Assay Predicts Coronary Heart Disease, Heart Failure, and Mortality in the Atherosclerosis Risk in Communities Study , 2011, Circulation.

[3]  J. Menke,et al.  Diagnostic accuracy and utility of coronary CT angiography with consideration of unevaluable results: A systematic review and multivariate Bayesian random-effects meta-analysis with intention to diagnose , 2016, European Radiology.

[4]  Maarten L. Simoons,et al.  The third universal definition of myocardial infarction , 2013 .

[5]  Michael E. Hall,et al.  Adenosine Stress Cardiovascular Magnetic Resonance–Observation Unit Management of Patients at Intermediate Risk for Acute Coronary Syndrome: A Possible Strategy for Reducing Healthcare-Related Costs , 2012, Current Treatment Options in Cardiovascular Medicine.

[6]  J. Hallas,et al.  Mortality rate in type 2 myocardial infarction: observations from an unselected hospital cohort. , 2014, The American journal of medicine.

[7]  F. Apple,et al.  Supply/demand type 2 myocardial infarction: should we be paying more attention? , 2014, Journal of the American College of Cardiology.

[8]  P. Collinson,et al.  Influence of population selection on the 99th percentile reference value for cardiac troponin assays. , 2012, Clinical chemistry.

[9]  R. Body,et al.  Serial Sampling of High-Sensitivity Cardiac Troponin T May Not Be Required for Prediction of Acute Myocardial Infarction Diagnosis in Chest Pain Patients with Highly Abnormal Concentrations at Presentation. , 2017, Clinical chemistry.

[10]  B. Lindahl,et al.  Prognostic Importance of Sex-Specific Cardiac Troponin T 99(th) Percentiles in Suspected Acute Coronary Syndrome. , 2016, The American journal of medicine.

[11]  H. Nathoe,et al.  Coronary CT Angiography for Suspected ACS in the Era of High-Sensitivity Troponins: Randomized Multicenter Study. , 2016, Journal of the American College of Cardiology.

[12]  R. Dreyer,et al.  Systematic Review of Patients Presenting With Suspected Myocardial Infarction and Nonobstructive Coronary Arteries , 2015, Circulation.

[13]  F. Bamberg,et al.  Highly sensitive troponin and coronary computed tomography angiography in the evaluation of suspected acute coronary syndrome in the emergency department. , 2016, European heart journal.

[14]  H. Katus,et al.  High-sensitivity cardiac troponin T for early prediction of evolving non-ST-segment elevation myocardial infarction in patients with suspected acute coronary syndrome and negative troponin results on admission. , 2010, Clinical chemistry.

[15]  C. Schindler,et al.  One-hour rule-out and rule-in of acute myocardial infarction using high-sensitivity cardiac troponin T. , 2012, Archives of internal medicine.

[16]  D. Newby,et al.  Comparison of the Efficacy and Safety of Early Rule-Out Pathways for Acute Myocardial Infarction , 2017, Circulation.

[17]  B. Lindahl,et al.  Consequences of implementing a cardiac troponin assay with improved sensitivity at Swedish coronary care units: an analysis from the SWEDEHEART registry. , 2016, European heart journal.

[18]  J. Schulz-Menger,et al.  Delayed Enhancement and T2-Weighted Cardiovascular Magnetic Resonance Imaging Differentiate Acute From Chronic Myocardial Infarction , 2004, Circulation.

[19]  D. Atar,et al.  ESC working group position paper on myocardial infarction with non-obstructive coronary arteries. , 2016, European heart journal.

[20]  W. Gibler,et al.  Risk Scores for Patients with Chest Pain: Evaluation in the Emergency Department , 2011, Current cardiology reviews.

[21]  Baris Gencer,et al.  ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation , 2011 .

[22]  J. Greenslade,et al.  Two-hour algorithm for triage toward rule-out and rule-in of acute myocardial infarction using high-sensitivity cardiac troponin T. , 2015, The American journal of medicine.

[23]  A. Khera,et al.  Association of troponin T detected with a highly sensitive assay and cardiac structure and mortality risk in the general population. , 2010, JAMA.

[24]  B. Pathik,et al.  Troponin-positive chest pain with unobstructed coronary arteries: incremental diagnostic value of cardiovascular magnetic resonance imaging. , 2016, European heart journal cardiovascular Imaging.

[25]  J. Smith,et al.  Diagnostic Accuracy of High-Sensitivity Cardiac Troponin T at Presentation Combined With History and ECG for Ruling Out Major Adverse Cardiac Events. , 2016, Annals of emergency medicine.

[26]  Ò. Miró,et al.  Prospective validation of a 1-hour algorithm to rule-out and rule-in acute myocardial infarction using a high-sensitivity cardiac troponin T assay , 2015, Canadian Medical Association Journal.

[27]  S. Blankenberg,et al.  Early discharge using single cardiac troponin and copeptin testing in patients with suspected acute coronary syndrome (ACS): a randomized, controlled clinical process study , 2014, European heart journal.

[28]  Fred S Apple,et al.  Determination of 19 cardiac troponin I and T assay 99th percentile values from a common presumably healthy population. , 2012, Clinical chemistry.

[29]  Pierre Coste,et al.  Should patients with acute coronary disease be stratified for management according to their risk? Derivation, external validation and outcomes using the updated GRACE risk score , 2014, BMJ Open.

[30]  B. Lindahl,et al.  Type 2 myocardial infarction in clinical practice , 2014, Heart.

[31]  A. Jaffe,et al.  In search for the Holy Grail: Suggestions for studies to define delta changes to diagnose or exclude acute myocardial infarction: a position paper from the study group on biomarkers of the Acute Cardiovascular Care Association , 2014, European heart journal. Acute cardiovascular care.

[32]  D. Atar,et al.  ESC Guidelines for the Management of Acute Myocardial Infarction in Patients Presenting With ST-Segment Elevation , 2013 .

[33]  C. Ayers,et al.  Prognostic Significance of High-Sensitivity Cardiac Troponin T Concentrations between the Limit of Blank and Limit of Detection in Community-Dwelling Adults: A Metaanalysis. , 2015, Clinical chemistry.

[34]  A. Hoes,et al.  A prospective validation of the HEART score for chest pain patients at the emergency department. , 2013, International journal of cardiology.

[35]  F. Apple,et al.  High-sensitivity cardiac troponin assays and unstable angina , 2018, European heart journal. Acute cardiovascular care.

[36]  J. Greenslade,et al.  Diagnosis of Myocardial Infarction Using a High-Sensitivity Troponin I 1-Hour Algorithm. , 2016, JAMA cardiology.

[37]  G. Hillis,et al.  A cluster randomized trial of objective risk assessment versus standard care for acute coronary syndromes: Rationale and design of the Australian GRACE Risk score Intervention Study (AGRIS). , 2015, American Heart Journal.

[38]  P. Doevendans,et al.  Chest pain in the emergency room: a multicenter validation of the HEART Score. , 2010, Critical pathways in cardiology.

[39]  E. Antman,et al.  The TIMI risk score for unstable angina/non-ST elevation MI: A method for prognostication and therapeutic decision making. , 2000, JAMA.

[40]  J. Alpert,et al.  How to use high-sensitivity cardiac troponins in acute cardiac care. , 2013, European heart journal.

[41]  P. Collinson,et al.  High-sensitivity cardiac troponin I at presentation in patients with suspected acute coronary syndrome: a cohort study , 2015, The Lancet.

[42]  P. Collinson,et al.  High sensitivity cardiac troponin and the under-diagnosis of myocardial infarction in women: prospective cohort study , 2015, BMJ : British Medical Journal.

[43]  Matthias Gutberlet,et al.  Cardiovascular Magnetic Resonance in Myocarditis: A JACC White Paper , 2009 .

[44]  A. Wu,et al.  Biological variation and reference change value of high-sensitivity troponin T in healthy individuals during short and intermediate follow-up periods. , 2011, Clinical chemistry.

[45]  Marc P. Bonaca,et al.  Real-world application of "delta" troponin: diagnostic and prognostic implications. , 2013, Journal of the American College of Cardiology.

[46]  A. Jaffe,et al.  High-sensitive troponin T measurements: what do we gain and what are the challenges? , 2012, European heart journal.

[47]  K. Eagle,et al.  Prediction of risk of death and myocardial infarction in the six months after presentation with acute coronary syndrome: prospective multinational observational study (GRACE) , 2006, BMJ : British Medical Journal.

[48]  A. Jaffe,et al.  IFCC educational materials on selected analytical and clinical applications of high sensitivity cardiac troponin assays. , 2015, Clinical biochemistry.

[49]  Fred S Apple,et al.  Analytical characteristics of high-sensitivity cardiac troponin assays. , 2012, Clinical chemistry.

[50]  J. Kelder,et al.  Chest pain in the emergency room: value of the HEART score , 2008, Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation.

[51]  A. Jaffe,et al.  Sensitive Troponin Assay and the Classification of Myocardial Infarction , 2015, The American journal of medicine.

[52]  G. Schuler,et al.  Clinical characteristics and cardiovascular magnetic resonance findings in stress (takotsubo) cardiomyopathy. , 2011, JAMA.

[53]  A. Jaffe,et al.  Editor’s Choice-Rule-in of acute myocardial infarction: Focus on troponin , 2017, European heart journal. Acute cardiovascular care.

[54]  J. Alpert,et al.  Diagnostic and therapeutic implications of type 2 myocardial infarction: review and commentary. , 2014, The American journal of medicine.

[55]  R. Body,et al.  Multicenter Evaluation of a 0-Hour/1-Hour Algorithm in the Diagnosis of Myocardial Infarction With High-Sensitivity Cardiac Troponin T. , 2016, Annals of emergency medicine.

[56]  H. Bueno,et al.  The race for higher sensitivity troponins, but for what prize? , 2016, European heart journal.

[57]  Anthony H. Aletras,et al.  Detecting Acute Coronary Syndrome in the Emergency Department With Cardiac Magnetic Resonance Imaging , 2003, Circulation.

[58]  A. Jaffe,et al.  Rapid rule out of acute myocardial infarction: novel biomarker-based strategies , 2017, European heart journal. Acute cardiovascular care.

[59]  F. Apple,et al.  Present and Future of Cardiac Troponin in Clinical Practice: A Paradigm Shift to High-Sensitivity Assays. , 2016, The American journal of medicine.

[60]  M. Petzold,et al.  Small changes in troponin T levels are common in patients with non-ST-segment elevation myocardial infarction and are linked to higher mortality. , 2013, Journal of the American College of Cardiology.

[61]  J. Seidman,et al.  Fulminant Myocarditis with Combination Immune Checkpoint Blockade. , 2016, The New England journal of medicine.